Evidence map›Paper›PMID 20107127›Full record

ArticleJournal of neurophysiology2010

Central cholinesterase inhibition enhances glutamatergic synaptic transmission.

Maxim Kozhemyakin, Karthik Rajasekaran, Jaideep Kapur

Abstract read
In one paragraph

Article in Journal of neurophysiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. A rapidFrontiers in cellular neuroscience · 2022
    Article
  9. Article
  10. Article
  11. Differential Impact of Severity and Duration ofFrontiers in cellular neuroscience · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Blood glutamate scavenging as a novel neuroprotective treatment for paraoxon intoxication.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Maxim KozhemyakinDept. of Neurology, University of Virginia-HSC, Charlottesville, VA 22908, USA.
Karthik Rajasekaran
Jaideep Kapur
University of Virginia · US

Funding

TREATMENT OF STATUS EPILEPTICUSR01NS040337 · NINDS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI KAPUR, JAIDEEP · 2000 to 2021
$5.0M
Neurosteroid Regulation of SeizuresR01NS044370 · NINDS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI KAPUR, JAIDEEP · 2003 to 2017
$4.1M
Mechanism and Treatment of nerve agent-induced seizuresU01NS058204 · NINDS · UNIVERSITY OF VIRGINIA · PI KAPUR, JAIDEEP · 2006 to 2010
$2.3M
NINDS NIH HHS R01 NS-040337NINDS NIH HHS R01 NS040337NINDS NIH HHS R01 NS044370NINDS NIH HHS U01 NS058204NINDS NIH HHS U01 NS-58204
6 · The paper itself

Abstract

Central cholinergic overstimulation results in prolonged seizures of status epilepticus in humans and experimental animals. Cellular mechanisms of underlying seizures caused by cholinergic stimulation remain uncertain, but enhanced glutamatergic transmission is a potential mechanism. Paraoxon, an organophosphate cholinesterase inhibitor, enhanced glutamatergic transmission on hippocampal granule cells synapses by increasing the frequency and amplitude of spontaneous excitatory postsynaptic currents (sEPSCs) in a concentration-dependent fashion. The amplitude of mEPSCs was not increased, which suggested the possibility of enhanced action potential-dependent release. Analysis of EPSCs evoked by minimal stimulation revealed reduced failures and increased amplitude of evoked responses. The ratio of amplitudes of EPSCs evoked by paired stimuli was also altered. The effect of paraoxon on glutamatergic transmission was blocked by the muscarinic antagonist atropine and partially mimicked by carbachol. The nicotinic receptor antagonist α -bungarotoxin did not block the effects of paraoxon; however, nicotine enhanced glutamatergic transmission. These studies suggested that cholinergic overstimulation enhances glutamatergic transmission by enhancing neurotransmitter release from presynaptic terminals.

Indexed as

AnimalsAtropineBungarotoxinsCarbacholCholinergic AgonistsCholinesterase InhibitorsExcitatory Postsynaptic PotentialsGlutamatesHippocampusModels, AnimalMuscarinic AntagonistsNicotineNicotinic AgonistsNicotinic AntagonistsParaoxonPatch-Clamp TechniquesAtropineBungarotoxinsCarbacholCholinergic AgonistsCholinesterase InhibitorsGlutamatesMuscarinic AntagonistsNicotineNicotinic AgonistsNicotinic AntagonistsParaoxonReceptors, Muscarinic

Identifiers

PMID20107127
PMCPMC2853275
OpenAlexW2045725535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.